https://www.targetedonc.com/view/update-shows-long-term-benefits-of-tagraxofusp-in-bpdcn
0
0
10/10/22 at 8:50pm
Organization
Targetedonc.com
Naveen Pemmaraju, MD discusses the long-term results of the STML-401-0114 trial that demonstrated the benefits of tagraxofusp-ezrs as a monotherapy for patients with blastic plasmacytoid dendritic cell neoplasms.
Create an account
or login to join the discussion